ArticleJournal of gastrointestinal oncology2022

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.

Kyaw L Aung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.